Determination of the avidity of specific IgG antibodies has become a generally accepted diagnostic aid for dating Toxoplasma infection. In this study, the Labsystems, VIDAS and EUROIMMUN Toxoplasma IgG avidity assays were compared on a series of 133 Toxoplasma IgG- and IgM-positive sera from symptomatic patients (n=28), from pregnant (n=43) and non-pregnant (n=26) women, and on 18 IgG-positive and IgM-negative sera from chronically infected patients. The results showed excellent concordance between the Labsystems and VIDAS tests in both the IgM-positive (r=0.82, κ=0.771) and IgM-negative (κ=0.609) sera, whilst the agreement of the EUROIMMUN assay with both the Labsystems and VIDAS tests in the IgM-positive sera was moderate (κ=0.575 and κ=0.525, respectively) and in the IgM-negative sera was poor (κ=0.000). Analysis of the kinetics of the maturation of avidity in 13 patients in whom follow-up sera were available showed that, despite a general trend of maturation, in two patients the avidity did not become high during 6 and 11 months of follow-up. In view of the clinical setting, in the symptomatic patients, despite one case of complete discrepancy and five cases of partial discrepancy, the Labsystems and VIDAS tests were in almost perfect agreement (κ=0.812), whilst the agreement in pregnant and non-pregnant women was substantial (κ=0.754 and κ=0.708, respectively). In conclusion, the Labsystems and VIDAS tests are equally reliable for the measurement of Toxoplasma IgG avidity; the choice of test should depend on the laboratory set-up. The EUROIMMUN test may be an acceptable alternative in resource-limited settings, but should be used prudently.
Alvarado-EsquivelC.,
SethiS.,
JanitschkeK.,
HahnH.,
LiesenfeldO.2002; Comparison of two commercially available avidity tests for Toxoplasma -specific IgG antibodies. Arch Med Res 33:520–523[CrossRef]
BobićB.,
ŠibalićD.,
Djurković-DjakovićO.1991; High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Gynecol Obstet Invest 31:182–184[CrossRef]
BrownS. E.,
HowardC. R.,
ZuckermanA. J.,
StewardM. W.1984; Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 2:184–187
DesmontsG.,
RemingtonJ. S.1980; Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol 11:562–568
FloriP.,
TardyL.,
PaturalH.,
BelleteB.,
VarletM. N.,
HafidJ.,
RaberinH.,
SungR. T.2004; Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol 11:669–674
FloriP.,
BelleteB.,
CrampeC.,
MaudryA.,
PaturalH.,
ChauleurC.,
HafidJ.,
RaberinH.,
Tran Manh SungR.2008; A technique for dating toxoplasmosis in pregnancy and comparison with the VIDAS anti-toxoplasma IgG avidity test. Clin Microbiol Infect 14:242–249[CrossRef]
HedmanK.,
LappalainenM.,
SeppäläI.,
MäkeläO.1989; Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159:736–740[CrossRef]
HorvathK. N.,
SzenasiZ.,
DankaJ.,
KucseraI.2005; Value of the IgG avidity in the diagnosis of recent toxoplasmosis: a comparative study of four commercially available anti- Toxoplasma gondii IgG avidity assays. Acta Parasitol 50:255–260
JenumP. A.,
Stray-PedersenB.,
GundersenA. G.1997; Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 35:1972–1977
Lefevre-PettazzoniM.,
Le CamS.,
WallonM.,
PeyronF.2006; Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis 25:687–693[CrossRef]
LiesenfeldO.,
MontoyaJ. G.,
KinneyS.,
PressC.,
RemingtonJ. S.2001; Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 183:1248–1253[CrossRef]
LogarJ.,
Novak-AntolicZ.,
ZoreA.1999; Specific IgG avidity – a supplementary assay in serological screening for toxoplasmosis in pregnancy. J Infect 38:61–63[CrossRef]
MontoyaJ. G.,
HuffmanH. B.,
RemingtonJ. S.2004; Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy. J Clin Microbiol 42:4627–4631[CrossRef]
PetersenE.,
BorobioM. V.,
GuyE.,
LiesenfeldO.,
MeroniV.,
NaessensA.,
SpranziE.,
ThulliezP.2005; European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii -specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 43:1570–1574[CrossRef]
SoulaF.,
FréalleE.,
Durand-JolyI.,
DutoitE.,
RoulandV.,
RenardE.,
Houfflin-DebargeV.,
SubtilD.,
CamusD.other authors2007; Intérêt de l'indice d'avidité des IgG pour le diagnostic d'exclusion d'une toxoplasmose récente: comparaison de la trousse Toxo IgG Avidité SFRI® à la trousse Toxo IgG Avidity VIDAS®
. Ann Biol Clin (Paris) 65:257–264